| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Differentiation and transcription factor gene therapy in experimental parkinson's disease: sonic hedgehog and Gli-1, but not Nurr-1, protect nigrostriatal cell bodies from 6-OHDA-induced neurodegeneration.
|
Mol Ther
|
2004
|
0.93
|
|
2
|
Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
|
Arzneimittelforschung
|
1985
|
0.80
|
|
3
|
Gene therapy for Parkinson's disease: recent achievements and remaining challenges.
|
Histol Histopathol
|
2001
|
0.79
|
|
4
|
Pharmacokinetics of Nimodipine. II. Communication: distribution, elimination and placental transfer in rats following single and multiple doses of [14C]nimodipine.
|
Arzneimittelforschung
|
1985
|
0.78
|
|
5
|
Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
|
Arzneimittelforschung
|
1988
|
0.76
|
|
6
|
Assessment of enterohepatic circulation of radioactivity following a single dose of [14C]nimodipine in the rat.
|
Eur J Drug Metab Pharmacokinet
|
1986
|
0.75
|
|
7
|
The pharmacokinetics of nitrendipine. II. Distribution to and elimination from organs and tissues of rats and dogs after single or repeated administration of [14C]nitrendipine.
|
Arzneimittelforschung
|
1988
|
0.75
|
|
8
|
Pharmacokinetics of nisoldipine. II. Distribution to and elimination from tissues and organs following single or repeated administration of [14C]nisoldipine to rats and dogs.
|
Arzneimittelforschung
|
1988
|
0.75
|
|
9
|
Mechanical assistance for enhancement of in vitro effectiveness for hydrodynamic thrombectomy.
|
Invest Radiol
|
1999
|
0.75
|
|
10
|
The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
|
Arzneimittelforschung
|
1988
|
0.75
|